AU-006

AU-006 is an orally active inhibitor of gastric acid secretion, with anti-ulcer effects. AU-006 does not rely on NO and mucus regulation. AU-006 significantly prevents 95% of gastric mucosal damage caused by ethanol and has broad-spectrum protective effects against chemical corrosive damage. AU-006 can be used for research on gastric ulcers[1]..

Product Specifications

CAS Number

[220831-12-9]

UNSPSC

12352005

Target

Endogenous Metabolite

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Endocrinology; Inflammation/Immunology

Smiles

FC(F)(F)OC1=CC=CC2=C1N=C(NCCCO)C3=C2N(C4=C(C)C=CC=C4)CC3

Molecular Formula

C22H22F3N3O2

Molecular Weight

417.42

References & Citations

[1]Cheon HG, et al. Pharmacological studies on the new quinoline derivative 1- (2-methylphenyl) -4-[ (3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect. Arzneimittelforschung. 1998 Dec;48 (12) :1168-71. PMID: 9893932.